Eburnamenine derivatives
US4065458A · kind A · utility
9Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 1976 |
| Grant date | Dec 27, 1977 |
| Priority date | — |
| Expiry date | Jun 9, 1996 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A heart and vasotropic pharmaceutical of the formula: ##STR1## wherein R represents a hydrogen atom or an acyl group, preferably a C.sub.1-15 alkylcarbonyl, C.sub.2-6 alkenylcarbonyl, or a phenyl- (C.sub.1-5)-alkylcarbonyl group or a benzoyl group optionally substituted with halogen, trihalomethyl, C.sub.1-4 or nitro And pharmaceutically acceptable acid addition and quaternary salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.